Summary

Overview
The Global Bioinformatics Services Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
A variety of computational and analytical services, including genomics and other omics disciplines, are included in the category of "bioinformatics services" and are aimed at processing, analyzing, and interpreting biological data. To make sense of the enormous volume of biological data produced by various high-throughput techniques, these services are crucial for researchers, scientists, and organizations working in the life sciences and biomedical sectors.
The study of DNA sequences, gene annotations, and structural differences in genomes are all included in genomic data analysis. Finding genes, regulatory components, and mutations is a frequent endeavor. Analysis of RNA-Seq data for the purposes of examining gene expression levels, alternative splicing, and non-coding RNA expression is frequently included in bioinformatics services. Protein and metabolite data are analyzed as part of proteomics and metabolomics research, which can shed light on biological functions and pathways.
Market Dynamics: Drivers
Increasing Research Activities
Data analysis is a crucial component of single-cell research although having access to bioinformatic expertise on-site is not always feasible. Researchers encounter challenges including having insufficient data to support hiring a bioinformatician on staff or retraining an already-existing team member. The market players are offering bioinformatics services that drive the market.
For instance, in January 2022, in light of the recently released RNAdia kit for single-cell research from Dolomite Bio. With upfront expenses making forecasting simple and single-cell RNA-sequencing hassle-free, Dolomite Bio introduced a bioinformatics service that can be purchased alongside the kit much like reagents.
In October 2022, Tempus Labs and VectorBuilder Biotechnology, two startup businesses based in the United States, raised USD 275 million for the development of precision medicine. To track a disease's progression and enroll patients in clinical trials, these businesses are widely utilizing Artificial Intelligence (AI) algorithms in clinical pipeline analysis.
In April 2022, the world's leading organization for the management and standardization of biological materials, ATCC, agreed with QIAGEN, a well-known provider of bioinformatics solutions, to share sequencing information from its collection of human and animal cell lines and biological materials with them.
In order to create and deliver high-value digital biology content for the biotechnology and pharmaceutical industries, QIAGEN Digital Insights, the bioinformatics division of QIAGEN, will create a database from this information. This will allow for the use of authenticated biological data sets to uncover new disease pathways and discover novel therapeutic targets.
Data Security and Privacy Concerns
Highly sensitive and private information can be found in genomic and medical data. The uptake of bioinformatics services may be hampered by worries about privacy and data breaches. Although important, observing data protection laws like the GDPR (General Data Protection Regulation) can be difficult and expensive.
Segment Analysis
The global bioinformatics services market is segmented based on product type, application, end-user and region.
The sequencing services segment accounted for approximately 45.5% of the market share
The process of figuring out the precise placement of nucleotides (A, C, G, and T) in a DNA or RNA molecule is known as sequencing. Numerous applications in biology, genetics, genomics, and other disciplines depend on this mechanism.
Accessible next-generation sequencing (NGS) services from Illumina include whole-genome sequencing services that are quick and of excellent quality. The user might want to think about outsourcing their genome sequencing projects if their lab doesn't already have access to a variety of sequencing tools and NGS knowledge.
User can take advantage of quick turnaround times, high-throughput equipment, library prep choices, and bioinformatics capabilities with their sequencing services. With their broad scientific knowledge and first-rate customer service, experience Genetic Energy.
In addition, Biosearch Technologies offers genotyping by sequencing, targeted genotyping by sequencing, metagenomics sequencing, microbial sequencing and whole genome sequencing, and sanger sequencing services.
Geographical Analysis
North America accounted for approximately 41.2% of the market share
North America has been a dominant force in the global bioinformatics services market. The active market players are driving the region. For instance, in June 2022, Agilent Technologies Inc., a leader in the field of genomics technology, reported that it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances with NVIDIA Clara Parabricks' advanced genomics analysis capabilities, Amazon Web Services (AWS) Graviton2 processors, and Amazon Elastic Compute Cloud (Amazon EC2) G5g instances with NVIDIA T4G Tensor Core GPUs.
In March 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc., a leader in genetic testing and precision medicine, expanded a strategic partnership to increase access to and availability of oncology homologous recombination deficiency (HRD) testing in the United States. Illumina TruSight Oncology 500 HRD (TSO 500 HRD), a test intended primarily for research purposes, is now accessible in the US as per the agreement.
The strengthened collaboration also creates a special companion diagnostic (CDx) alliance for the pharmaceutical sector, enabling greater clinical study for gene-based, targeted medicines. The item is now available for purchase and is prepared for delivery to the US. Distributable kits and centralized laboratory services are provided by Myriad and Illumina, respectively.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global bioinformatics services market. Due to the necessity to comprehend the genetic differences of the SARS-CoV-2 virus, the pandemic increased the demand for genomic sequencing and analysis. As a result, businesses that provide services in genomics and bioinformatics saw a surge in business.
On the other side, due to supply chain interruptions and laboratory closures, numerous research initiatives had to be postponed or temporarily stopped. Consequently, the demand for bioinformatics services was impacted.
By Product Type
• Sequencing Services
• Data Analysis Services
• Gene Expression
• Drug Discovery Services
• Data Base Management
• Others
By Application
• Metabolomics
• Proteomics
• Transcriptomics
• Chemoinformatics & Drug Design
• Genomics
• Others
By End-User
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academic Institutes & Research Centers
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Illumina, Inc., PerkinElmer Inc., Premier Biosoft, QIAGEN N.V., Strand Life Sciences, Inc., Thermo Fisher Scientific, Agilent Technologies, Inc., BGI Group, Biomatters Geneious, and Biomax Informatics AG.
Key Developments
• In January 2021, Illumina, Inc. is turning genomic data bottlenecks into catalysts with the introduction of Illumina Connected Analytics (ICA). The comprehensive, private, cloud-based data platform offered by this innovative and integrated bioinformatics solution enables users to manage, analyze, and study huge volumes of multi-omic data in a safe, adaptable, and secure setting.
Why Purchase the Report?
• To visualize the global bioinformatics services market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of bioinformatics services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bioinformatics services market report would provide approximately 61 tables, 63 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Research Activities
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Data Security and Privacy Concerns
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Sequencing Services*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Data Analysis Services
7.4. Gene Expression
7.5. Drug Discovery Services
7.6. Data Base Management
7.7. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Metabolomics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Proteomics
8.4. Transcriptomics
8.5. Chemoinformatics & Drug Design
8.6. Genomics
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pharmaceutical & Biotechnology Companies
9.4. Academic Institutes & Research Centers
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Illumina, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. PerkinElmer Inc.
12.3. Premier Biosoft
12.4. QIAGEN N.V.
12.5. Strand Life Sciences, Inc.
12.6. Thermo Fisher Scientific
12.7. Agilent Technologies, Inc.
12.8. BGI Group
12.9. Biomatters Geneious
12.10. Biomax Informatics AG
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us